Biomark™ HD
Production-scale throughput with exquisite single-cell sensitivity and consistent results
Receive your quote directly from the manufacturer.
Fast, accurate and very meaningful in our analyses.
DNA Amplification
Great results and very sensitive. Perfect for showing the amplified DNA markers during malaria eradication.
Review Date: 18 Feb 2019 | Standard BioTools Inc.
No more compromising for quality. With the Biomark™ HD system, you get reliable production-scale throughput and exquisite single-cell sensitivity, with a wide variety of sample types and chemistry choices to accommodate the most genomic applications. Now you can run entire projects from research to validation to routine screening on a single system with the flexibility you want and the consistency you need. Anything else we can help with?
- Flexible - Design experiments to match your needs across the widest range of genomic applications.
- Sensitive - Detect unique molecular signatures in individual cells and rare cell populations.
- Fast - Accelerate discovery with a higher throughput and automated workflow.
- Efficient - Conserve precious samples—and funding—with lower reagent use and nanoliter reactions.
Fluidigm launches new Biomark X microfluidics platform
The new microfluidics platform, Biomark X, has a broad menu of applications and promises to streamline operations to reduce hands-on time
FDA grants emergency use authorization for home collection kit for Advanta Dx SARS-CoV-2 RT-PCR assay
Collaboration agreement to market AZOVA COVID-19 test collection kit online
George Mason University employs rapid-result COVID-19 tests to control the spread of virus on campus
The testing capacity provided by the Fluidigm system aims to help the university limit the spread of the virus
Fluidigm granted EUA for saliva-based Advanta Dx SARS-CoV-2 RT-PCR assay
The real-time PCR workflow has a capacity of up to 6,000 tests per day per system, and demonstrated 100% agreement with authorized nasopharyngeal assays
GnomeDX files for FDA EUA for RT-PCR COVID-19 test utilizing the Fluidigm Biomark HD Platform
The test is intended to expand availability of COVID-19 screening resources in central Ohio
